直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

McRO Saga Ends with Affirmation of Non-Infringement and Unresolved Question of Enablement

June 2, 2020

Authored and Edited by Linda J. Thayer; Kara A. Specht; Elizabeth D. Ferrill

In McRO, Inc. dba Planet Blue v. Bandai Namco Games America Inc., et al., No. 2019-1577 (Fed. Cir. May 20, 2020), the Federal Circuit affirmed a district court’s decision of noninfringement but, for a second time, reversed the finding of invalidity, remanding to the Central District of California for reconsideration of enablement. Because Defendants offered to withdraw their invalidity counterclaims without prejudice, this long-running dispute has likely come to an end.

McRO asserted a patent related to a method of “automatically” generating 3-D animations depicting lip movements and facial expressions using morph weight sets, including a simple exemplary set of rules. In 2012, McRO sued over 20 video game developers, accusing software applications with “bones animation” to make video game images look three-dimensional. The CDCA found the claims invalid under Section 101. The Federal Circuit reversed finding that claims recited a technical means for accomplishing a particular objective do not present preemption concerns, so long as there exists the possibility of alternative technical means for accomplishing that same objective. 

Once returned to the CDCA, the court returned a decision of noninfringement, finding the “bones animation” method used by Defendants did not practice the "morph weight set" limitation as narrowly understood based on the intrinsic evidence in the patent itself, not a broader interpretation that may exist in the field of art. In November 2018, the court granted defendants’ motion for summary judgment of invalidity, noting that defendants had identified two animation techniques—the accused “bones” animation and the prior art BALDI system—not enabled by the specification.

The Federal Circuit affirmed the finding of noninfringement. The Court, however, reversed the lower court’s finding of invalidity for failing to meet the enablement requirement because it failed to provide specific examples sufficient to support summary judgment. The Court summarized that Section 112 requires enablement of “only the claimed invention,” not matter outside the claims. Because both examples proffered by Defendants and considered by the lower court—“bones” animation and the BALDI system—were outside the scope of the claims, they could not support nonenablement. Judge Taranto wrote, "We do not go so far as to hold that there is a triable issue of fact on enablement—instead, we vacate the judgment and remand for the district court to consider how to proceed,” noting that Defendants had offered to drop their counterclaims of invalidity.

Tags

Enablement (35 USC § 112), summary judgment, video games

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Related Offices

Washington, DC

Contacts

Kara A. Specht
Partner
Atlanta, GA
+1 404 653 6481
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2020 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information. 

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP